Education
About Us
Working with TipRanks
Follow Us
PuraPharm Corp. Ltd. (HK:1498)
:1498
1498 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.49 - HK$0.89
Previous CloseN/A
Volume23.50K
Average Volume (3M)94.55K
Market Cap
HK$236.96M
Enterprise ValueHK$649.80M
Total Cash (Recent Filing)HK$104.88M
Total Debt (Recent Filing)HK$548.48M
Price to Earnings (P/E)―
Beta0.29
Next Earnings
Sep 02, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 31, 2017Dividend YieldN/A
Share Statistics
EPS (TTM)-0.22
Shares Outstanding395,897,280
10 Day Avg. Volume121,550
30 Day Avg. Volume94,550
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
PuraPharm Corp. Ltd. News
PremiumCompany Announcements
PuraPharm Further Delays Board Meeting for 2024 Results
PremiumCompany Announcements
PuraPharm Postpones Board Meeting to Finalize Annual Results
PremiumCompany Announcements
PuraPharm Projects Reduced Losses for FY2024 Amid Cost Control EffortsPremiumCompany Announcements
PuraPharm Schedules Board Meeting to Approve 2024 Annual Results
PremiumCompany Announcements
PuraPharm Announces Effective Date for Capital Reduction and Subdivision
PremiumCompany Announcements
PuraPharm Advances Capital Restructuring with Court Approval
PremiumCompany Announcements
PuraPharm Announces Update on Capital Restructuring
PremiumCompany Announcements
PuraPharm Corp. Ltd. Announces Auditor Change---
1498 FAQ
What was PuraPharm Corp. Ltd.’s price range in the past 12 months?
PuraPharm Corp. Ltd. lowest stock price was HK$0.49 and its highest was HK$0.89 in the past 12 months.
What is PuraPharm Corp. Ltd.’s market cap?
PuraPharm Corp. Ltd.’s market cap is HK$236.96M.
When is PuraPharm Corp. Ltd.’s upcoming earnings report date?
PuraPharm Corp. Ltd.’s upcoming earnings report date is Sep 02, 2025 which is in 156 days.
How were PuraPharm Corp. Ltd.’s earnings last quarter?
Currently, no data Available
Is PuraPharm Corp. Ltd. overvalued?
According to Wall Street analysts PuraPharm Corp. Ltd.’s price is currently Overvalued.
Does PuraPharm Corp. Ltd. pay dividends?
PuraPharm Corp. Ltd. pays a Annually dividend of HK$0.02 which represents an annual dividend yield of N/A. See more information on PuraPharm Corp. Ltd. dividends here
What is PuraPharm Corp. Ltd.’s EPS estimate?
PuraPharm Corp. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PuraPharm Corp. Ltd. have?
PuraPharm Corp. Ltd. has 395,897,280 shares outstanding.
What happened to PuraPharm Corp. Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of PuraPharm Corp. Ltd.?
Currently, no hedge funds are holding shares in HK:1498
---
PuraPharm Corp. Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.71%
12-Months-Change
Fundamentals
Return on Equity
-50.23%
Trailing 12-Months
Asset Growth
-17.40%
Trailing 12-Months
Company Description
PuraPharm Corp. Ltd.
PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Haveron, Oncozac, and Immuzac names. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong's name that provide Chinese medicine services and concentrated Chinese medicine granules products. In addition, the company engages in the plantation and trading of raw Chinese herbs; and manufacture and sale of traditional Chinese medicine decoction pieces. Further, it provides modernized Chinese medicine services; and Chinese medical diagnostic services. The company sells its products to hospitals, healthcare institutions, and medicine practitioners, as well as operates an online store. It operates 43 Nong's clinics in Hong Kong and 1 Nong's clinic in Guangxi, China. The company was founded in 1998 and is headquartered in Tai Po, Hong Kong.
---
Technical Analysis
Sino Biopharmaceutical
―
Shanghai Pharmaceuticals Holding Co
―
North Asia Strategic Holdings Limited
―
China Resources Pharmaceutical Group Ltd.
―
Zhongzhi Pharmaceutical Holdings Limited
―
---